3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
CNS
13
Sarcoma
10
Other hematologic neoplasm
2
Lymphoid
2
Genitourinary
2
Thoracic
1
Plasma cell
1
Other solid neoplasm
1
NET
1
Myeloid
1
Head & Neck
1
Gynecologic
1
Gastrointestinal
1
Endocrine
1
Dermatologic
1
Breast
1
Conditions
Head and Neck Neoplasms
34
Squamous Cell Carcinoma of Head and Neck
32
Nasopharyngeal Carcinoma
22
Mouth Neoplasms
10
Oropharyngeal Neoplasms
8
Carcinoma, Squamous Cell
8
Laryngeal Neoplasms
7
Neoplasms
6
Melanoma
5
Lung Neoplasms
5
Colorectal Neoplasms
5
Pharyngeal Neoplasms
4
Pancreatic Neoplasms
4
Ovarian Neoplasms
4
Kidney Neoplasms
4
Breast Neoplasms
4
Stomach Neoplasms
3
Neoplasm Metastasis
3
Uterine Cervical Neoplasms
2
Tongue Neoplasms
2
Thyroid Neoplasms
2
Skin Neoplasms
2
Recurrence
2
Paranasal Sinus Neoplasms
2
Nasopharyngeal Neoplasms
2
Lymphoma, Non-Hodgkin
2
Liver Neoplasms
2
Laryngeal Diseases
2
Hypopharyngeal Neoplasms
2
Glioblastoma
2
Interventions
Peripheral Blood Stem Cell Transplantation
3
Filgrastim
3
Cisplatin
3
selpercatinib
2
pembrolizumab
2
Etoposide
2
Carboplatin
2
regorafenib
1
pentetreotide
1
pazopanib
1
etoposide phosphate
1
epothilone B
1
entrectinib
1
durvalumab
1
carbon-11 methionine
1
cabozantinib
1
aflibercept
1
Thiotepa
1
Temozolomide
1
Tamoxifen
1
Surveys and Questionnaires
1
Radiotherapy
1
Quality of Life
1
Patient Reported Outcome Measures
1
Paclitaxel
1
Nivolumab
1
NEO212
1
Molecular Diagnostic Techniques
1
Methionine
1
MLN 8237
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Central Nervous System Neoplasms
×
Drug Therapy
×
Head & Neck
×
Clear all
NCT04028479
2024-12-18
ROOT
Taproot Health
Completed
167 enrolled